Tools commonly used in the Laboratories-Biological industry for day-to-day tasks and operations.

• Microscopes
• Centrifuges
• Pipettes
• Spectrophotometers
• Incubators
• Electrophoresis equipment
• PCR machines
• Flow cytometers
• Gel documentation systems
• Automated liquid handling systems

Common products and services typical of NAICS Code 621511-04, illustrating the main business activities and contributions to the market.

• Genetic testing
• Pathology services
• Microbiology testing
• Immunology testing
• Toxicology testing
• Clinical trials
• Biobanking
• Pharmacogenomics
• Environmental testing
• Food safety testing

The specific certifications, permits, licenses, and regulatory compliance requirements within the United States for this industry.

• Clinical Laboratory Improvement Amendments (CLIA): CLIA regulates laboratory testing and requires clinical laboratories to be certified by the Centers for Medicare & Medicaid Services (CMS) before they can accept human samples for diagnostic testing. The certification process ensures that laboratories meet quality standards and follow proper testing procedures.
• College Of American Pathologists (CAP) Accreditation: CAP is a leading organization that provides accreditation to laboratories that meet their rigorous standards for quality and patient care. CAP accreditation is recognized worldwide as a symbol of excellence in laboratory medicine.
• Clinical Laboratory Scientist (CLS) Certification: CLS certification is a professional credential that demonstrates a laboratory professional's knowledge and expertise in the field of laboratory medicine. The certification is offered by the American Society for Clinical Pathology (ASCP).
• Medical Laboratory Scientist (MLS) Certification: MLS certification is a professional credential that demonstrates a laboratory professional's knowledge and expertise in the field of laboratory medicine. The certification is offered by the American Society for Clinical Pathology (ASCP).
• Clinical Laboratory Technologist (CLT) Certification: CLT certification is a professional credential that demonstrates a laboratory professional's knowledge and expertise in the field of laboratory medicine. The certification is offered by the American Medical Technologists (AMT).

A concise historical narrative of NAICS Code 621511-04 covering global milestones and recent developments within the United States.

• The biological laboratory industry has a long and rich history dating back to the 17th century when Antonie van Leeuwenhoek invented the microscope and discovered microorganisms. In the 19th century, Louis Pasteur made significant contributions to the field of microbiology, including the development of pasteurization and the germ theory of disease. In the 20th century, the discovery of DNA and the development of genetic engineering revolutionized the industry. In the United States, the biological laboratory industry has seen significant growth since the 1970s due to advancements in technology and increased demand for medical testing and research.

The anticipated future trajectory of the NAICS 621511-04 industry in the USA, offering insights into potential trends, innovations, and challenges expected to shape its landscape.

• Growth Prediction: Growing

  The future outlook for the Laboratories-Biological industry in the USA is positive. The industry is expected to grow due to the increasing demand for diagnostic testing services, the rise in chronic diseases, and the aging population. The industry is also expected to benefit from the advancements in technology, such as the development of new diagnostic tools and the increasing use of automation in laboratories. Additionally, the COVID-19 pandemic has highlighted the importance of diagnostic testing, which is expected to further drive the growth of the industry in the coming years.

Recent groundbreaking advancements and milestones in the Laboratories-Biological industry, reflecting notable innovations that have reshaped its landscape.

• CRISPR Gene Editing Technology: CRISPR technology has revolutionized the field of biological research and has the potential to transform the healthcare industry. It allows scientists to edit genes with unprecedented precision, which could lead to the development of new treatments for genetic diseases.
• Liquid Biopsy: Liquid biopsy is a non-invasive diagnostic test that detects cancer by analyzing a patient's blood sample. It has the potential to replace traditional tissue biopsies, which are invasive and can be painful for patients.
• 3D Bioprinting: 3D bioprinting is a technology that allows scientists to create living tissues and organs using a 3D printer. This technology has the potential to revolutionize the field of regenerative medicine and could lead to the development of new treatments for a wide range of diseases.
• Artificial Intelligence (AI): AI has the potential to transform the field of diagnostics by improving the accuracy and speed of diagnostic tests. It can also help identify patterns in large datasets, which could lead to the development of new treatments and therapies.
• Next-Generation Sequencing (NGS): NGS is a technology that allows scientists to sequence DNA and RNA at a much faster and cheaper rate than traditional sequencing methods. It has the potential to revolutionize the field of genomics and could lead to the development of new treatments for genetic diseases.